Shares of RUA Life Sciences plc (LON:RUA – Get Free Report) traded up 5.9% during trading on Tuesday . The company traded as high as GBX 21.92 and last traded at GBX 20.65. Approximately 193,484 shares traded hands during mid-day trading, a decline of 19% from the average daily volume of 237,918 shares. The stock had previously closed at GBX 19.50.
RUA Life Sciences Price Performance
The stock has a market capitalization of £12.82 million, a price-to-earnings ratio of -2.61 and a beta of 0.95. The company has a quick ratio of 7.32, a current ratio of 4.64 and a debt-to-equity ratio of 18.95. The business’s 50 day simple moving average is GBX 20.03 and its 200-day simple moving average is GBX 16.11.
RUA Life Sciences (LON:RUA – Get Free Report) last released its earnings results on Tuesday, June 30th. The company reported GBX (0.33) EPS for the quarter. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.
About RUA Life Sciences
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.
Featured Stories
- Five stocks we like better than RUA Life Sciences
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
- Abivax: Wall Street Catches Up to the Data
Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
